KL-6 as an indicator for lymphocytic interstitial pneumonia (LIP) in a human T-lymphotrophic virus type 1 (HTLV-1) carrier

Annals of Hematology

Volumn 81, Issue 8, 2002, Pages 474-477

  Ishikawa, N ^a   Awaya, Y ^a   Maeda, H ^b   Miyazaki, M ^c   Fujitaka, K ^a   Yamasaki, M ^a   Kondo, K ^a   Oguri, T ^a   Isobe, T ^a   Kohno, N ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Hiroshima Prefecture Hiroshima Hospital   (Japan)

^c Miyoshi General Hospital   (Japan)

Author keywords

High resolution computed tomography; Human T lymphotropic virus type 1; Krebs der Lungen 6; Lactate dehydrogenase; Lymphocytic interstitial pneumonia

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; KREBS DER LUNGEN 6; METHYLPREDNISOLONE; MUCIN 1; PREDNISONE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE MARKER; DRUG MEGADOSE; DYSPNEA; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LYMPHOCYTIC INTERSTITIAL PNEUMONIA; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; SYNDROME; THORAX RADIOGRAPHY; VIRUS CARRIER;

ADRENAL CORTEX HORMONES; ANTIGENS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARRIER STATE; FEMALE; GLYCOPROTEINS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MUCINS; TOMOGRAPHY, X-RAY COMPUTED; TRACHEA; TREATMENT OUTCOME;

EID: 0036939519     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0465-4     Document Type: Article

References (20)

1. Carrinton CB, Liebow AA (1966) Lymphocytic interstitial pneumonia (abstract). Am J Pathol 48:36a
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410
3. Hamada H, Kohno N, Yokoyama A, Hirasawa Y, Hiwada K, Sakatani M, Ueda E (1998) KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts. Intern Med 37:307-310
4. Hansson L, Folkesson HG, Andersson R, Jeppsson B, Holst E, Westrom BR, Ahren B (1992) Increased passage of bovine serum albumin over the respiratory tract after intratracheal instillation during septic shock in rats. Eur Surg Res 24:45-53
5. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB (1986) Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 78:1513-1522
6. Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS (1997) Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 156:109-115
7. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M (1988) Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18:203-216
8. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M (1989) New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96:68-73
9. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M (1992) Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102:117-122
10. Kohno N, Inoue Y, Hamada H, Fujioka S, Fujino S, Yokoyama A, Hiwada K, Ueda N, Akiyama M (1994) Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer [Suppl 8]:81-83
11. Kohno N (1999) Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 46:151-158
12. Matsuse T, Fukuchi Y, Hsu CY, Nagase T, Higashimoto N, Teramoto S, Matsui H, Sudo E, Kida K, Morinari H, Fukayama M, Ouchi Y, Orimo H (1996) Detection of human T lymphotropic virus type 1 proviral DNA in patients with diffuse panbronchiolitis. Respirology 1:139-144
13. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N (1992) HTLV-1 uveitis: a distinct clinical entity caused by HTLV-1. Jpn J Cancer Res 83:236-239
14. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-1 associated myelopathy, a new clinical entity. Lancet 1:1031-1032
15. Setoguchi Y, Takahashi S, Nukiwa T, Kira S (1991) Detection of human T-cell lymphotropic virus type 1-related antibodies in patients with lymphocytic interstitial pneumonia. Am Rev Respir Dis 144:1361-1365
16. Stahel RA, Gilks WR, Lehmann HP, Schenker T (1994) Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis. Int J Cancer [Suppl 8]:6-26
17. Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR (1978) Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88:616-621
18. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S (1987) T-lymphocyte alveolitis in HTLV-1-associated myelopathy. Lancet 2:1220
19. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-492
20. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K (1998) Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158:1680-1684